John Griffin (Trades, Portfolio) is the president of Blue Ridge Capital, an investment partnership that he founded in 1996. Griffin was known as legendary investor Julian Robertson (Trades, Portfolio)'s right hand man. He and a few others are named as Tiger Cubs as they worked with Julian Robertson (Trades, Portfolio) at Tiger Funds. Griffin is an adjunct professor of finance at Columbia Business School and a visiting professor at the University of Virginia. He began his career as a financial analyst for Morgan Stanley Merchant Banking Group before moving on to Tiger Management, where he became president in 1993.
Blue Ridge Capital, at the end of the first quarter of this year, was composed of 47 stocks with a total value of $8,773 million, and the following are the 5 new stocks he recently bought.
Kraft Foods Group Inc (KRFT)
The company has a market cap of $50.04 billion and is a consumer packaged food and beverage companies in North America and worldwide. It manufactures and markets food and beverage products .
With this trade, the investor bought 1,900,000 shares (1.89% of his portfolio and 0.32% of KRFT’s outstanding shares).
After this buy, the price of the stock rose by 29% and is now trading with a P/E (ttm) of 53.90 (-6.77% from its 52 weeks high and +59.65% from its 52 weeks low).
It has positive returns (ROE +19.00% and ROA +4.15%) but looks overpriced by 261% according to the DCF model.
Over the last 12 months, the company's revenue grew by 1.40%, EBITDA dropped by 58.00% and EPS by 65.30%.
Fleetcor Technologies, Inc (FLT)
The company has a market cap of $14.04 billion and is an independent provider of payment products and services. The Company offers fuel cards, commercial payment and data solutions, stored value solutions, and workforce payment products and services .
With this trade, the investor bought 1,058,000 shares (1.82% of his portfolio and 1.15% of FLT’s outstanding shares).
After this buy, the price of the stock increased by 3% and is now trading with a P/E (ttm) of 35.10 (-7.70% from its 52 weeks high and +25.94% from its 52 weeks low).
It has positive returns (ROE +19.52% and ROA +6.53%) but looks overpriced by 138% according to the DCF model.
Over the last 5 years, the company's revenue rose by 25.40%, EBITDA grew by 29.70%, EPS growth rate is 35.90% and free cash flow grew by 24.80%
CDK Global Inc (CDK)
The company has a market cap of $8.73 billion and is a global provider, both integrated technology and digital marketing/advertising solutions to the automotive retail industry.
With this trade, the investor bought 3,060,000 shares (1.63% of his portfolio and 1.91% of CDK’s outstanding shares).
After this buy, the price of the stock increased by 19% and is now trading with a P/E (ttm) of 64.10 (-1.34% from its 52 weeks high and +117.84% from its 52 weeks low).
It has positive returns (ROE +16.30% and ROA +7.43%) but looks overpriced by 334% according to the DCF model.
Over the last 12 months, the company's revenue rose by 40.00%, EBITDA grew by 33.70% and EPS growth rate is 21.30%.
HD Supply Holdings Inc (HDS)
The company has a market cap of $6.47 billion and it provides an array of products and value-add services to the infrastructure and power, MRO, and specialty construction sectors in the U.S. and Canada.
With this trade, the investor bought 2,900,000 shares (1.03% of his portfolio and 1.47% of HDS’s outstanding shares).
After this buy, the price of the stock rose by 13% and is now trading near its 52 weeks high (-2.96% from its 52 weeks high and +47.93% from its 52 weeks low).
It has positive returns (ROC +38.63% and ROA +0.05%) but over the last 12 months, the company's revenue dropped by 10.80%, EBITDA grew by 3.00%.
Tekmira Pharmaceuticals Corp (TKMR)
The company has a market cap of $772.15 million and it develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada .
With this trade, the investor bought 1,700,000 shares (0.34% of his portfolio and 3.14% of TKMR’s outstanding shares).
After this buy, the price of the stock tanked by 30% and is now trading with a forward P/E (ttm) of 10.47 (-52.42% from its 52 weeks high and +60.72% from its 52 weeks low).
It has negative returns (ROE -16.62% and ROA -12.62) and over the last 5 years, the company's revenue dropped by 15.30%, while EBITDA grew by 8.10% and book value by 18.20%.
